Psychiatry lacks biomarkers. Can this EEG ballcap get a base hit? Featuring Universal Brain
Universal Brain just announced an FDA 510(k) clearance for its Neurotique™ platform, which offers a five-minute assessment to measure cognitive and emotional brain function in support of psychiatric diagnosis and treatment.
The device is an eight-channel dry EEG baseball cap with two electrooculography (EOG) electrodes to detect eye movement, along with a rechargeable battery and integrated digital testing platform that uses event related potentials (ERP) to generate specific task-based measurements.
CEO Kazu Okuda founded Universal Brain in 2022 and recruited Greg Hajcak, a clinical psychologist and professor at Santa Clara University to join as chief scientist in 2024. Hajack formerly led Google X’s Project Amber, a three-year attempt to build a custom neurotech device to discover a single biomarker for depression that came to a premature conclusion in 2020.
